The mechanism of the therapeutic and prophylactic effects of carbamazepine (CBZ) in affective psychose.s is unknown but may in part be related to the potent competitive interaction of CBZ with adenosine-binding sites in the brain. The antioonvuls4l:At and sedative properties of CBZ are reminiscent of the effects evoked by adenosine-agonists and contrast sharply with the opposite aclions of adenosine-antagonists like caffeine. However. indirect evidence suggests an antagonist-rather than an agonist-like activity of CBZ at adenosi11e-receptors. We have used various model systems, in which adenosine receptor subtypes mediate different second messenger-responses, to investigate this apparent paradox. CBZ was found to antagonize the Ai·ret:eptor-mediated inhibition of cydic AMP accumulation in cultured astroblasts and in GH 3 -cells. Furthermore, CBZ also inh.ibits the adenosi.ne-induced increase in the Ievel of cyclic ".MP in cultured astrobla.sts, which is med.iated by low-affinity A 2 b-receptors. ln contrast, CBZ does not block the inhibition elicited by adenosine-agonists of the agonist-induced increased formation of inositolphosphates in human neutrophils, which is mediated by high-affinity A 23 -receptors. The specific antagonism by CBZ of A 1 -but not of high-affinity A 23 -receptors was further supported by binding experiments using rat brain membranes. These results suggest tbat the paradox of CBZ's antagonistic effects at adenosine-receptors might be at least partially reconciled by a selective anta%onistic action of CBZ at A 1 recertors but not at high-affinity A2a-receptors.
The tricyclic iminostilbene-derivative carbarnazepine (CBZ) is weil known for its anticonvulsive properties and its efficacy in the treatment of paroJ(ysrnal pain syndromes. Over the last few years evidence has accumulated that CBZ is also effective in the treatment of acute mania and as a prophylactic agent in manic-depressive illness (for recent reviews see Elphick. 1988; Post, 1987 Post, , 1990 Schmidt and Greif, 1987) . The anticonvulsive properties of CBZ may predominantly be due to allosteric blockade of voltage-sensitive Na~· cbanne)s (for review see Catteral, 1987) , while GABA 8 mechanisms may account for its antinociceptive properlies (for review see Post. 1990 ). Among the various other potential mechanisms that may be responsible for CBZ's efficacy in affective psychoses (for review see Elphick. 1988 ; Post, 1987 Post, , 1990 binding sites in the brain has received special attention (Fujiwara et al.. 1987 : Gasser et al., 1988 Marangos et al.. 1985 , 1987a .b,c~ Plüllis. 1984 : Skerritt et al., 1983a Weir et al.. 1984) . The clinical properties of CBZ are reminiscent of the anticonvulsive. sedative and anxio1ytic effects of adenosine-agonists and cantrast sharply to the opposite actions of adenosine-antagonists like caffeine ( for review see Bridges et al.. 1988) . Although this would suggest that CBZ might have adenosineagonist properties, there is substantial indirect evidence to the contrary. Chronic administration of CBZ to rats, like that of caffeine, results in persistent up-regulation of adenosine binding sites in the brain (Daval et al., 1989; Marangos et al., 1985 Marangos et al., , 1987b )_ In additio~ CBZ's effects on adenosine bi.nding sites are affected by temperature and guanyl nucleotides in a manner typical for adenosine antagonists (Marangos et aL. 1987b ) . Possible mixed agonist~antagonist properties of CBZ andjor differential effects on adenosine receptor subtypes have been suggested to account for thls parado;:: (Post, 1987) . Adenosine receplors have been originally distinguished as A 1 -receptors t~t inhibtt and A 2 -receptors thal activate adenylate cyclase (Londos et al .• 1980; Van Calker et al., 1978 . Based on ·more recent evidence indicating that adenosine receptor-reguJated events might in several cases also be independent of cyclic AMP. adenosine receptors are now classified according to the structure-activity-reJationship (SAR) of various adcnosine analogues (Hamprecht and Van Calker, 1985) . In addition, A 2 -receptors could be fur~ ther subdivided into high-affinity A 211 ·receptors and Iow-affinity A 2 b-receptors, which apparently also shuw differences in the SAR of newly deveJoped adenosine~ analogues (Bruns et al., 1987 C0 2 ) at 37°C. The medium was changed two to three tirnes a week, depending on the ceJJ density and the cells were subcultivated every 1-2 weeks. Cells were detached by vigorous pipetting, plated on tissue culture dishes 60 mm in diameter (Nunc) and grown to a cell density of 1-3 million cells per dish.
Astrohlast cultures were prepared by mechanical dissociation of newborn mouse or rat brain and cultivated as described previously (Van Calker et al., 1979) .
Isolation of neutrophils
Human neutrophils were isolated from heparinized whole blood obtained from healthy volunteers by means of sedimentation through dextran (0. 6% w jv) followed by centrifugation through Ficoii-Hypaque and hypotonic Iysis of contaminating erythrocytes (Dougherty et al.. 1984; Boyum, 1984) .
Measurement of inositol plzosphate production
Washed neutrophils ~re suspended (50 million cells per ml) in Eagle's basal medium (with Earle's salts) without inositol containing deoxyribonuclease (50 Ujm)) • fetal calf serum (3%) and 50 JLCi eH)inositol per ml and incubated at 37°C for 4-5 h in a shaking water bath. Thereafter cells were centrifuged, and washed two times with ice-cold Hank's balanced salt solution (HBSS) containing 20 mM N-2-hydroxyethylpiperazine-N'-2-ethansulfonic acid (HEPES), pH 7.4. 6 million cells were then incubated with HBSS at 37°C in the presence of cytochalasin B (5 ~-tM), KCN (1 mM), LiCJ (10 mM) and other additions as required in a final volume of 1 ml. Controls received the corresponding amount of vehicle ( dimethylsulphoxide, final concentr.l· tion 0.05% ). The incubations were terminated at tbe desired times by addition of 1 ml ice-cold trichloroacetic acid (20% w jv). The samples were centrifuged and the pellet was washed once with distilled water. The combined supernatants were extracted with diethylether and fractionated by anion exchange chromatography on small Dowex columns as described previously (Van Calker et al., 1987) .
Cultured GH 3 -cells and astroblasts were labeled with 
Determination of cyclic AMP
Dishes containing GH 3 -cells or astroblasts were washed twice with incubation buffer (118 mM NaCI, 4.7 mM KCl, 3 mM CaCI, 1.2 mM MgCI, 1.2 mM KH 2 P0 4 , 0.5 mM EDTA, 10 mM glucose and 20 mM HEPES, pH 7.4) and thereafter incubated at 37°C for 10 min with 2 ml of the same buffer containing the various additions. Controls received the same amount of vehicle (dimethylsulfoxide, final concentrati0n 0.05%). Theincubations were terminated by removal of the buffer and the addition of 1 ml ice-coJd trichloroacetic acid (10% w jv). After removal of the trichloroacetic acid by extraction with diethyl ether (3 times 4 ml), the samples were fractionated by anion chromatography on small Dowex columns (Bio Rad AG 1 X 2) as described (Van Calker et al., 1979) . The cyclic AMP content in the samples was determined by a commercially available protein binding assay (Amersham).
6. Radioligand binding
Membranes from whole rat brain and rat striatum were prepared as described previously (Lohse et al., 1987 ). Binding of [ 3 H)5' N-ethylcarboxamido-adenosine (eHJNECA) (10 nM) in the presence of N 6 -cyclopentyiadenosine (CPA) (50 nM) to striatal membranes was performed according to Bruns et al. (1986) with the modifications described earlier (Lohse et al.. 1987) . Binding assays using [
3 H]CCPA and [ 3 H]DPCPX were done as described previously (Lohse et al., 1987; Klotz et al., 1989) .
Results

Effects of carbamazepine on adenosine Arreceptors
Adenosine inhibits via A 1 -receptors the increase in the accumulation of cyclic AMP. which is evoked in Cells were obtained by mechanical diss.x:iation of newbom rat l>rain and cultivated for 16 days as described previously (Van Calker ~t a1.. 1979). They were th"'l incubated for 10 min with carbamazepine or vehkle, before the hlracellulac content of cyclic AMP was detenr,ined as uescribed in Materialsand methods.
• P < 0.01. Other deta'~s are as in fig. l . Similar results were obtained in two additional independent experiments.
tured astroglia cells (Van CaJker et al., 1978 ) is antagonized by CBZ (data not shown).
Effects of carbamazepine on (/ow-affinity) adenosine A 1 b-receptors
Adenosine and its analogues stimulate via adenosine A 2 -receptors the accumulation of cyclic AMP in primary E' c.. 
-5 log (NECA) (M) cultures of perinatal rodent brain, mainly consisting of astroglia cells (V an Calker et al., 1979) . The l0w-affinity A 2 -receptors that mediate this effect resemble those which have been calJed A:u .. (Bruns et al., 1987) and are found in virtually all grey matter areas of the brain (Daly et aJ.. 1983) . CBZ attenuates the incrcase in the JevcJ of cydic AMP e·voked by adenosine in tl.e astroglia-rich cultures ( fig. 2) .
Ef!ects of carbuma:epine 011 the udenosine A .'a -receptor-meaiated inhibition of inositol phosphare formation in human neutrophils
In human neutrophils adenosine and its analogues elicit only a minimal increase in the Ievel of cyclic AMP but provoke a pronounced inhibition of the agonist-induced accumulc~tion of inositoJ phosphates. which is indeper.dent of cyclic AMP (Van Calker and Steber, submitted) . This effecf is mediated via high-affinity adenosine A 2 -receptors (Van Calker and Steber. submitted). which resemble those found e.g. in the striatum and called •A 2 a' (Bruns et aL 1987) . In contrast to its effects on A 1 -and A 20 -receptors, CBZ does not attenuate this effect but induces. if anything, rather a slight potentiation of the inhi'>ition evoked by the adenosine-agonist 5 '~N -ethylcarboxamidoadenosine (NECA) (fig. 3) .
Elfecrs of carbamazepine on the binding of radio-/abeled A 1 -and A 1 -ligands at rat brain rn~mbranes
To further analyze the effects of CBZ at adenosine receptor subtypes we measured its interaction wlth A 1 -,-., receptors in binding assays with membranes from rat brain performed with the highly A 1 -selective radioligands 2-ch loro-N 6 -[
3 H ]cyclopentyladenosine <('H)CCPA, an agonist) (Klotz et al., 1989) (Lohse et al.. 1987) . The action of CBZ at high affini ty A za -receptors was evaluated with membranes from rat striatum, using [ 3 H}NECA as a radioligand in the presence of N 6 -cyclopentyladenosine (CPA) to block the binding to A 1 -sites (Bruns et al., 1986) . CßZ inhibited the binding of both [ 
Discussion
The inhibitory effects of CBZ on adenosine-evoked second-messenger responses that are reported in the present study provide the first direct evidence that CBZ inhibits second messenger-responses mediated by adenosine A 1 -receptors but not those mediated by high-affinity A 2 a-receptors. CBZ induces a parallel shift to the right of the dose-response curve for the A 1 -induced inhibition of tbe VIP-stimulated cyclic AMP accumulation in GH 3 -cells ( fig. 1) , as expected for a competitive interaction. In contrast, the A2a-mediated inhibition of the fMLP-stimulated formation of inositol phosphates in human ncutrophils is not antagonized by CBZ ( fig. 3) .
In addition to its antagonistic effect at A 1 -receptors CBZ also inhibits the A 2 b-receptor-mediated increase in cyclic AMP in cultured astroglia cells ( fig. 2) . Similarly, CBZ at high concentrations also attenuates the adenosine-evoked increase in the Ievel of cyclic AMP in brain slices (Lewin and Bleck, 1977; Skenitt et al., 1983a; Weir et al., 1984) , which is probably also mediated by low-affinity A 2 b-receptors (Daly et al., 1983) . These effects may be at Jeast partially due to ~:-. antagonism of CBZ also at A 2 b-receptors. However, the dose-response curve depicted in fig. 2 is not typical for a competitive interaction of CBZ with A 2 b-receptors. Furthennore, by mechanisms other than competitive inhibition, CBZ also weakly attenuates the increase in the Ievel of cyclic AMP evoked by the activation of putaüve A 2 a-receptors in PC12 cells and platelets (Daly et al., 1988) . Thus, mechanisms other than competitive inhibition could also account for thc inbibition by CBZ of cyclic AMP acoJmulation in various tissues and cell·types. A more detailed analysis of the mechanism of CBZ's inhibition of the adenosine-induced increase in cyclic AMP in astroblasts is hampered by the low affinity of the A 2 b· receptors. (fig. 4) . While the present work was in progress, similar conclusions have been drawn from binding studies performed with Nr>-cyclohexyl- [3H] adenosine and [
3 H]NECA (Clark and Post, 1989 ). CBZ's selective antagonism at A 1 -receptors may explain why its profile of clinical and behavioral effects is different from that of non-selP.ctive adenosineantagonists like theophylline and caffeine. Indeed, 8-cyclopentyltheophylline (CPT). which acts as a selective A 1 -antagonist in vivo, does not have the stimulating effect on locomotor activity which occurs with theophylline. On the other hand, CPT has proconvulsant properlies in animal models (for review see Bridges et al., 1988) . Thus, CBZ's A 1 -antagonistic properties are probably not involved in its anticonvulsant action, as already concluded from other evidence (Post, 1987) .
Although apparently not involved in its anti(.;vlH·-ül-sive effects, the blockade of Acreceptors by CBZ might be related to its efficacy as a prophylactic, antimanic and possibly also antidepressive agent in affective psychoses. Several A 1 -antagonists show antidepressantIike activities in animal models (see Bridge:; for review). In addition, effe~tive antidep; essive treatments like electroconvulsive shock (Newma:: et al., 1984; Gleiter et al., 1989) and REM sleep depri\·ation (Y anik and Radulovacki, 198'7~ !!p-regulate A 1 -receptors, similar to chronic treatment with CBZ (Marangos et al., 1985 (Marangos et al., , 1987b Daval et al., 1989) .
s~me of CBZ's compJex effects on various neurotransmitter systems seen in behavioral and biochemical studies (for review see Elphick. 1988; Post, 1987 Post, , 1990 could be indirectly mediated by the A 1 -antagonistic action of CBZ, since the release of many excitatory and inhibitory neurotransmitters is inhibited by adenosine via A 1~r eceptors (for review see Bridgeset aJ., 1988) .
The use of CBZ as an :.lternative to Iithium in the treatment of manic~depressive iJiness raises the question of whether or not there are also similarities in the biochemical effects of both drugs. The inhibitory effects of chronic Iithium treatment on the agonist~stimulated increase in the accumulation of cyclic AMP (Belmaker, 1981; Ebstein et al., 1988) and inositol phosphates (Casebolt and Jope, 1989; Ebstein et al., 1988; Elphick et al., 1988; Godfrey et ai., 1989; Kendall and Nahors.k!, 1987 ) may be involved in lithium's antimanic and prophylactic properties. CBZ iru'libits the accumulation of cyclic AMP in brain slices stimulai.ed by noradrena· line, ouabain and adenosine (Lewin and Bleck, 1977; Palmer et al., 1979; Skerritt et al., 1983a; Weir et al., 1984) , although only at high concentrations. CBZ's effects on the agonist-evoked formation of inositol phos-289 phates are controversial (Elphick et al., 1988: MeDermatt and Logan, 1989) .
In addition to these possible direct effects on second messenger generation, CBZ might also interfere with the potent synergistic interactions of adenosine with vari.:>us neurotransmitters in the regulation of both cyclic AMP and inositol phosphate formation (EI-Etr et al., 1989; Hili and Kendall, 1987; Hol1ingsworth et al., 1986) . The blockade by CBZ of A 1 -and possibly also A 2 b-receptors should inhibi t these synergistic effects of adenosine and could t"ereby profoundly alter the regulation by various neurotransmitters of both second messenger systems. Thus, Iithium ions and carbamazepine might, via different mechanisms, both elicit a dampening effect on second messenger generation that could be important for their similar profile of clinical efficacy in affective psychoses.
